Our Specialty Pharmaceuticals segment posted strong increases in net sales and operating income, benefiting from the sale of higher-margin branded and generic pharmaceutical products.
由于诉讼费用昂贵且及时,仿制药公司通常会和解并同意推迟发布其版本的药物。
Because litigation is costly and timely, the generic drug companies often settle and agree to delay the release of their version of the drug..
四)药品生产企业是开展仿制药一致性评价的主体。
(3) The pharmaceutical production enterprise is the main body for the evaluation of the quality consistency of generic drugs.
为了预测通用生物制剂的价格,研究人员将通用生物制剂的理论模型与仿制药市场的历史数据相结合。
In order to predict prices of generic biologics, the researchers combined a theoretical model of generic biologics with historical data from the generic pharmaceutical market.
Civica Rx is working toward becoming an FDA-approved manufacturer, and will either directly manufacture generic drugs or subcontract manufacturing to reputable partners.
在2022年,仿制药销售预计将占到全球医药总销售额的29.2%,在2017年这一占比大约为28%。
Global generic drug sales are expected to make up 29.2% of the total pharmaceutical sales worldwide in 2022, compared to approximately 28 in 2017.
去年,中国制药公司获得美国食品和药物管理局批准的38种仿制药,比2016年的22项获得批准。
Last year, Chinese pharmaceutical firms obtained U.S. Food and Drug Administration approvals for 38 generic drugs, up from 22 such approvals in 2016.”.
去年,宾夕法尼亚大学的研究人员发现,默认选项的改变将仿制药处方率从75%提高到98%。
Last year, Penn researchers found that a change to default options increased generic drug prescribing rates from 75 percent to 98 percent.
因此要靠推动制药行业竞争来降低医疗费用--也就是说要允许仿制药的生产和销售。
Lowering health-care costs thus requires greater competition in the pharmaceutical industry- and that means allowing the manufacture and distribution of generic drugs.
Nathaniel has represented software and energy companies, brand name and generic drug manufacturers, and chemical suppliers in various aspects of patent proceedings in Canada.
去年,中国制药公司获得美国食品和药物管理局批准的38种仿制药,比2016年的22项获得批准。
Last year, Chinese pharmaceuticals obtained U.S. Food and Drug Administration approvals for 38 generic drugs, up from 22 such approvals in 2016.
但他指出,这些药物都是专利药,如果存在足够的利益,可以由仿制药公司生产。
But the drugs are off patent, he notes, and could be made by generic drug companies if enough interest existed.
SN,该交易将使其在快速增长的拉丁美洲市场的品牌仿制药业务翻番.
SN in a $2.9 billion deal that will more than double its branded generic drugs business in the fast-growing Latin American market.
中文
Bahasa indonesia
日本語
عربى
Български
বাংলা
Český
Dansk
Deutsch
Ελληνικά
Español
Suomi
Français
עִברִית
हिंदी
Hrvatski
Magyar
Italiano
Қазақ
한국어
മലയാളം
मराठी
Bahasa malay
Nederlands
Norsk
Polski
Português
Română
Русский
Slovenský
Slovenski
Српски
Svenska
தமிழ்
తెలుగు
ไทย
Tagalog
Turkce
Українська
اردو
Tiếng việt